Navigation Links
Find New Cancer Treatments at cureLauncher
Date:1/24/2013

Bloomfield Hills, MI (PRWEB) January 24, 2013

Less than 5 percent of Americans know where to find information about clinical trials, according to the Center for Information & Study on Clinical Research. cureLauncher solves that problem. It gives everyone a place to find new treatments and connect with lifesaving treatment options.

Now, cureLauncher has every enrolling breast cancer trial in the country available on its website. There are 400 trials at 7,500 locations across the U.S. that offer new breast cancer treatment options. cureLauncher has translated the complex, medical terminology into easy to understand English.

When people visit cureLauncher, they can review information about these trials and the entry questions to see if a trial is right for them. Anyone can complete the Request Form to participate or call cureLauncher directly to see if they qualify. This service is free to all users.

cureLauncher’s founders, Stephen Goldner and David Fuehrer, appeared on the Stupid Cancer Radio Program live from New York City on January 21st to discuss trial options. “cureLauncher makes it easy for people to find treatment that’s right for them”, said David Fuehrer. “Our mission is to provide a place where people feel comfortable learning about clinical trials and cutting edge, new medical treatments”.

Dr. Max Wicha, Director of the University of Michigan’s Cancer Center, was on the Stupid Cancer Show with cureLauncher. “Only about 3 percent of cancer patients decide to enter a clinical trial, even though the very best treatment for them may be in a trial”, said Dr. Wicha. “Particularly now, when we have so many new options to treat cancer it’s so important that patients understand they have options to get advantages of these leading treatments”.

To learn more, visit http://www.curelauncher.com

About cureLauncher
CureLauncher.com is an online community that connects people to lifesaving clinical trials across the U.S. Discover your power to find new cancer treatment options, right now.

Read the full story at http://www.prweb.com/releases/New_Cancer_Treatments/cureLauncher/prweb10356876.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cornell bioengineers discover the natural switch that controls spread of breast cancer cells
2. New Shared Synthetic Replikin Cancer Vaccines
3. NextBio Teams With Emory University and the Aflac Cancer Center to Improve Outcomes for Children with Medulloblastoma
4. Genetic basis of high-risk childhood cancer points to possible new drug treatment strategy
5. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
6. University of Colorado Cancer Center Study Finds That Body's Ibuprofen, SPARC, Reduces Inflammation and Thus Bladder Cancer Development and Metastasis
7. The Blood Sugar-Cardiac-Cancer Connection
8. Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference
9. Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
10. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
11. Breast cancer cells growing in 3D-matrix revert to normal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
Breaking Biology Technology:
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
Breaking Biology News(10 mins):